SKI Market

A+| A| A-|

Indian Indices

Sensex

77,017.79 -251.61
( -0.33%)

Global Indices

Nasdaq

48,970.60 -549.68
(-1.11%)

Dow Jones

7,222.65 -28.47
(-0.39%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,363.93 -14.87
(-0.14%)

Forex

USD-INR

94.82 -0.13
(-0.14%)

EUR-INR

111.15 0.04
(0.04%)

GBP-INR

128.70 0.21
(0.16%)

JPY-INR

0.60 0.00
(0.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fine Line Circuits Ltd

Industry : Electronics - Components

BSE Code

ISIN Demat

Book Value()

517264

INE087E01011

18.6607069

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

139.59

32.9

EPS(TTM)

Face Value()

Div & Yield %

0.49

Back

Transgene Biotek reports consolidated net loss of Rs 0.39 crore in the September 2025 quarter

Nov 15,2025

Net Loss of Transgene Biotek reported to Rs 0.39 crore in the quarter ended September 2025 as against net loss of Rs 0.07 crore during the previous quarter ended September 2024. Sales declined 16.67% to Rs 0.05 crore in the quarter ended September 2025 as against Rs 0.06 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.05	0.06	-17
OPM %	-140.00	-116.67	-
PBDT	-0.34	-0.05	-580
PBT	-0.39	-0.07	-457
NP	-0.39	-0.07	-457

77,017.79 -251.61 ( -0.33%)

48,970.60 -549.68 (-1.11%)

7,222.65 -28.47 (-0.39%)

59,594.47 309.55 (0.52%)

10,363.93 -14.87 (-0.14%)

94.82 -0.13 (-0.14%)

111.15 0.04 (0.04%)

128.70 0.21 (0.16%)

0.60 0.00 (0.59%)